Summary
Highlights
MOTS-c is not synthetic; it's naturally produced by mitochondria in the body. Levels decline with age and metabolic dysfunction, improving with exercise. Exogenous MOTS-c amplifies this natural signaling path, making it a recognized signal that the body already understands.
MOTS-c disrupts the folate cycle, leading to the accumulation of AICAR, a distress signal that activates AMPK. This activation improves insulin sensitivity, activates GLUT transporters for independent blood sugar uptake by muscle cells, and initiates mitochondrial biogenesis. It's often compared to 'exercise in a bottle' due to these effects and can also regulate stress response genes directly within the cell nucleus under metabolic stress.
The concern about MOTS-c and cancer is theoretical, based on energy-sensing pathways. Current research indicates lower MOTS-c levels in some cancer patients (e.g., ovarian cancer), and exogenous MOTS-c has shown to inhibit proliferation in ovarian cancer models, not promote it. The decline of MOTS-c with age correlates with rising cancer risk, suggesting a protective role, not a harmful one.
Common reactions to MOTS-c include histamine responses (flushing, skin reactions) due to its positive charge interacting with mast cells, and fatigue. Fatigue often occurs when mitochondria are already compromised and cannot meet the increased demand. To mitigate these, start with low doses, inject at room temperature, consider antihistamines or intramuscular injection for histamine reactions, and support mitochondrial repair (e.g., with SS-31) before or alongside MOTS-c.
A common protocol involves 10 mg once a week, administered in the morning. Some may load faster with 10 mg three times a week for two weeks, then revert to once weekly. Cycles typically last 8-12 weeks, followed by a 1-2 month break. It's recommended to repair mitochondria with peptides like SS-31 before introducing MOTS-c. While MOTS-c and O304 both activate AMPK, MOTS-c can be complemented with Sloop 332 and GLP-1 medications, as they work through different pathways. MOTS-c is considered an advanced peptide, best introduced after establishing a foundational metabolic protocol.